Haemonetics Corp (HAE)
71.48
+0.32
(+0.45%)
USD |
NYSE |
Nov 01, 16:00
71.45
-0.03
(-0.04%)
After-Hours: 20:00
Haemonetics Net Income (Quarterly): 38.37M for June 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 38.37M |
| March 31, 2024 | 20.37M |
| December 31, 2023 | 31.24M |
| September 30, 2023 | 24.91M |
| June 30, 2023 | 41.04M |
| March 31, 2023 | 29.38M |
| December 31, 2022 | 32.94M |
| September 30, 2022 | 33.20M |
| June 30, 2022 | 19.88M |
| March 31, 2022 | 9.741M |
| December 31, 2021 | 23.23M |
| September 30, 2021 | 14.86M |
| June 30, 2021 | -4.454M |
| March 31, 2021 | -11.04M |
| December 31, 2020 | 31.88M |
| September 30, 2020 | 48.10M |
| June 30, 2020 | 10.53M |
| March 31, 2020 | 17.62M |
| December 31, 2019 | 29.90M |
| September 30, 2019 | 37.49M |
| June 30, 2019 | -8.479M |
| March 31, 2019 | 20.84M |
| December 31, 2018 | 18.28M |
| September 30, 2018 | 18.73M |
| June 30, 2018 | -2.819M |
| Date | Value |
|---|---|
| March 31, 2018 | 11.88M |
| December 31, 2017 | -6.547M |
| September 30, 2017 | 20.10M |
| June 30, 2017 | 20.14M |
| March 31, 2017 | -51.14M |
| December 31, 2016 | 15.39M |
| September 30, 2016 | 19.82M |
| June 30, 2016 | -10.35M |
| March 31, 2016 | -8.735M |
| December 31, 2015 | -59.44M |
| September 30, 2015 | 12.86M |
| June 30, 2015 | -0.267M |
| March 31, 2015 | -2.93M |
| December 31, 2014 | 15.99M |
| September 30, 2014 | 7.487M |
| June 30, 2014 | -3.649M |
| March 31, 2014 | 10.18M |
| December 31, 2013 | 16.29M |
| September 30, 2013 | 16.55M |
| June 30, 2013 | -7.874M |
| March 31, 2013 | 12.56M |
| December 31, 2012 | 9.904M |
| September 30, 2012 | 6.547M |
| June 30, 2012 | 9.787M |
| March 31, 2012 | 17.81M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-11.04M
Minimum
Mar 2021
48.10M
Maximum
Sep 2020
23.25M
Average
24.91M
Median
Sep 2023
Net Income (Quarterly) Benchmarks
| Boston Scientific Corp | 468.00M |
| Baxter International Inc | -314.00M |
| Teleflex Inc | 111.00M |
| Cerus Corp | -2.934M |
| Insulet Corp | 188.60M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 336.17M |
| Total Expenses (Quarterly) | 296.42M |
| EPS Diluted (Quarterly) | 0.74 |
| Enterprise Value | 4.537B |
| Gross Profit Margin (Quarterly) | 52.03% |
| Profit Margin (Quarterly) | 11.41% |
| Earnings Yield | 3.12% |
| Operating Earnings Yield | 4.33% |
| Normalized Earnings Yield | 3.288 |